00000000|MMI|12.93|Epistaxis|C0014591|[patf]|["EPISTAXIS"-tx-1-"epistaxis"-noun-0]|TX|66/9|C08.460.261;C09.603.261;C23.550.414.712
00000000|MMI|3.68|Admission date:Time Stamp -- Date and Time:Point in time:^Patient:Quantitative|C2598112|[clna]|["Admission date"-tx-1-"Admission Date"-noun-0]|TX|86/14|
00000000|MMI|3.68|Date of admission|C1302393|[tmco]|["Admission date"-tx-1-"Admission Date"-noun-0]|TX|86/14|
00000000|MMI|3.65|Report status|C0586177|[fndg]|["Report status"-tx-1-"Report Status"-noun-0]|TX|111/13|
00000000|MMI|3.64|10 - 12|C3843787|[fndg]|["10 - 12"-tx-1-"10 12"-fraction-0]|TX|41/2,52/2|
00000000|MMI|3.59|23|C0450348|[qnco]|["23"-tx-1-"23"-fraction-0]|TX|44/2|
00000000|MMI|3.59|Pyrexia of unknown origin (excl puerperal)|C0856281|[sosy]|["puo"-tx-1-"PUO"-noun-0]|TX|12/3|
00000000|MMI|3.47|Diagnostic interview schedule|C0451119|[inpr]|["DIS"-tx-1-"DIS"-noun-0]|TX|80/3|
00000000|MMI|3.47|Discontinued|C1444662|[fndg]|["DIS"-tx-1-"DIS"-noun-0]|TX|80/3|
00000000|MMI|356.70|Coumadin|C0699129|[orch,phsu]|["Coumadin"-tx-36-"coumadin"-noun-0,"Coumadin"-tx-33-"coumadin"-noun-0,"Coumadin"-tx-27-"coumadin"-noun-0,"Coumadin"-tx-24-"coumadin"-noun-0,"Coumadin"-tx-22-"coumadin"-noun-0,"Coumadin"-tx-20-"coumadin"-noun-0,"Coumadin"-tx-19-"coumadin"-noun-0,"Coumadin"-tx-16-"coumadin"-noun-0,"Coumadin"-tx-15-"coumadin"-noun-0,"Coumadin"-tx-7-"coumadin"-noun-0]|TX|4644/8;4437/8;4183/8;3900/8;3818/8;3610/8;3559/8;3387/8;[2710/8],[2807/8];2086/8|D03.383.663.283.446.520.914;D03.438.150.446.520.914
00000000|MMI|177.92|Deep Vein Thrombosis|C0149871|[dsyn]|["DVT NOS"-tx-25-"DVT"-noun-0,"DVT NOS"-tx-24-"DVT"-noun-0,"DVT NOS"-tx-16-"DVT"-noun-0,"DVT NOS"-tx-15-"DVT"-noun-0,"DVT NOS"-tx-7-"DVT"-noun-0,"DVT NOS"-tx-7-"dvt"-noun-0,"Deep Venous Thrombosis"-tx-7-"deep venous thrombosis"-noun-0]|TX|[4017/3],[4072/3];[3871/3],[3978/3];3380/3;2703/3;2079/3;1764/3;1770/22|C14.907.355.830.925
00000000|MMI|143.52|Epistaxis|C0014591|[patf]|["NOSEBLEED"-tx-20-"nose bleed"-noun-0,"EPISTAXIS"-tx-18-"Epistaxis"-noun-0,"NOSEBLEED"-tx-16-"nosebleeds"-noun-1,"NOSEBLEED"-tx-9-"nosebleed"-noun-0,"EPISTAXIS"-tx-7-"epistaxis"-noun-0,"EPISTAXIS"-tx-7-"epistaxis"-noun-1,"NOSEBLEED"-tx-7-"nosebleed"-noun-1]|TX|3641/10;3498/9;3483/10;2374/9;[1338/9],[1427/9],[2045/9],[2192/9];[1338/9],[1427/9],[2045/9],[2192/9];1950/9|C08.460.261;C09.603.261;C23.550.414.712
00000000|MMI|138.55|Togo|C0040363|[geoa]|["TO"-tx-35-"to"-adv-0,"TO"-tx-24-"to"-adv-0,"TO"-tx-21-"to"-adv-0,"TO"-tx-15-"to"-adv-0,"TO"-tx-11-"to"-adv-0,"TO"-tx-8-"to"-adv-0,"TO"-tx-7-"TO"-adv-0]|TX|4568/2;3884/2;3742/2;3304/2;2496/2;2262/2;1140/2|Z01.058.290.190.800
00000000|MMI|138.55|Tryptophanase|C0041260|[aapp,enzy]|["TO"-tx-35-"to"-adv-0,"TO"-tx-24-"to"-adv-0,"TO"-tx-21-"to"-adv-0,"TO"-tx-15-"to"-adv-0,"TO"-tx-11-"to"-adv-0,"TO"-tx-8-"to"-adv-0,"TO"-tx-7-"TO"-adv-0]|TX|4568/2;3884/2;3742/2;3304/2;2496/2;2262/2;1140/2|D08.811.520.224.800
00000000|MMI|119.49|Obesity, Morbid|C0028756|[dsyn]|["Morbid Obesity"-tx-25-"morbid obesity"-noun-0,"Morbid Obesity"-tx-16-"morbid obesity"-noun-1,"Morbid Obesity"-tx-15-"morbid obesity"-noun-1,"Morbid Obesity"-tx-7-"morbid obesity"-noun-1]|TX|4030/14;3443/14;2773/14;2149/14|C18.654.726.500.700;C23.888.144.699.500.500;E01.370.600.115.100.160.120.699.500.500;G07.100.100.160.120.699.500.500
00000000|MMI|101.55|Patient Discharge|C0030685|[hlca]|["Discharge"-tx-40-"DISCHARGE"-noun-0,"Discharge"-tx-36-"DISCHARGE"-noun-0,"Discharge"-tx-7-"DISCHARGE"-noun-0,"Discharge"-tx-1-"DISCHARGE"-noun-0,"Patient Discharge"-tx-1-"DISCHARGE PATIENT"-noun-0]|TX|4830/9;4599/9;1358/9;38/9;130/17|E02.204.125;E02.760.400.610;N02.421.192.125;N02.421.585.400.610;N04.590.233.727.210.125
00000000|MMI|101.18|Tarceva|C1135136|[orch,phsu]|["Tarceva"-tx-36-"tarceva"-noun-0,"Tarceva"-tx-34-"TARCEVA"-noun-0,"Tarceva"-tx-21-"tarceva"-noun-0,"Tarceva"-tx-16-"tarceva"-noun-0,"Tarceva"-tx-15-"tarceva"-noun-0,"Tarceva"-tx-7-"tarceva"-noun-0]|TX|4657/7;4476/7;3750/7;3433/7;[2763/7],[2837/7];2139/7|D03.438.786.375
00000000|MMI|80.08|International Normalized Ratio|C0525032|[lbpr]|["INR"-tx-19-"INR"-noun-0,"INR"-tx-15-"INR"-noun-0,"INR"-tx-12-"INR"-noun-0]|TX|3584/3;[3109/3],[3252/3];2560/3|E01.370.225.625.115.320;E05.200.625.115.320
00000000|MMI|77.71|Hippocampus Proper|C3887642|[bpoc]|["CA"-tx-16-"ca"-adj-0,"CA"-tx-15-"ca"-adj-0,"CA"-tx-7-"ca"-adj-0]|TX|3413/2;2743/2;2119/2|A08.186.211.464.405;A08.186.211.730.885.287.500.345
00000000|MMI|68.28|Coding|C0009219|[ocac]|["code"-tx-33-"code"-noun-0,"code"-tx-3-"CODE"-noun-0,"code"-tx-3-"code"-noun-0]|TX|4392/4;313/4;331/4|N04.452.758.708.200.400.500;N04.452.859.564.274;N05.715.360.300.715.500.249;N06.850.520.308.940.968.249
00000000|MMI|67.53|Hematocrit procedure|C0018935|[lbpr]|["HCT"-tx-30-"Hct"-noun-0,"HCT"-tx-15-"hct"-noun-0,"HCT"-tx-12-"hct"-noun-0]|TX|4294/3;[3080/3],[3241/3];2520/3|E01.370.225.625.400;E05.200.625.400;G09.188.370.374
00000000|MMI|67.53|Hemopoietic stem cell transplant|C0472699|[topp]|["HCT"-tx-30-"Hct"-noun-0,"HCT"-tx-15-"hct"-noun-0,"HCT"-tx-12-"hct"-noun-0]|TX|4294/3;[3080/3],[3241/3];2520/3|E04.936.225.687.500
00000000|MMI|66.53|Lisinopril|C0065374|[aapp,phsu]|["Lysinopril"-tx-15-"lisinopril"-noun-0,"Lysinopril"-tx-6-"LISINOPRIL"-noun-0,"Lysinopril"-tx-4-"LISINOPRIL"-noun-0]|TX|2824/10;[847/10],[916/10];688/10|D12.644.456.345.600
00000000|MMI|61.19|Dicloxacillin|C0012093|[antb,orch]|["DICLOXACILLIN"-tx-15-"dicloxacillin"-noun-0,"DICLOXACILLIN"-tx-7-"DICLOXACILLIN"-noun-0]|TX|2915/13;1307/13|D02.065.589.099.750.625.150.205;D02.886.108.750.625.150.205;D03.438.260.825.625.150.205;D03.605.084.737.625.150.205;D04.075.080.875.099.221.750.625.150.205
00000000|MMI|60.37|Atrial Fibrillation|C0004238|[dsyn]|["AFib"-tx-15-"Afib"-noun-0,"AFib"-tx-7-"Afib"-noun-0,"AFib"-tx-7-"afib"-noun-0,"ATRIAL FIBRILLATION"-tx-7-"atrial fibrillation"-noun-0]|TX|2721/4;2097/4;1735/4;1742/19|C14.280.067.198;C23.550.073.198
00000000|MMI|54.84|Anemia, Pernicious|C0002892|[dsyn]|["Pernicious anaemia"-tx-7-"pernicious anemia"-noun-0]|TX|[1695/17],[1715/17]|C15.378.071.252.196.500;C18.654.521.500.133.699.923.280
00000000|MMI|52.34|Hemorrhage|C0019080|[patf]|["BLEEDING"-tx-29-"bleeding"-noun-1,"BLEEDING"-tx-15-"bleeding"-noun-1,"bleed"-tx-11-"bleed"-verb-0,"BLEEDING"-tx-9-"bleeding"-noun-0,"bleed"-tx-8-"bleed"-verb-0]|TX|4284/8;2990/8;2499/5;2416/8;2289/5|C23.550.414
00000000|MMI|49.70|Cellulitis|C0007642|[patf]|["CELLULITIS"-tx-7-"cellulitis"-noun-0]|TX|[1682/10],[1816/10],[1829/10]|C01.539.800.130;C01.539.830.200;C17.300.185;C23.550.470.756.200
00000000|MMI|49.03|Food-Drug Interactions|C0242785|[dsyn]|["Interaction, Food-Drug"-tx-6-"Food/Drug Interaction"-noun-0,"Interaction, Food-Drug"-tx-4-"Food/Drug Interaction"-noun-0,"Interaction, Food-Drug"-tx-3-"Food/Drug Interaction"-noun-0]|TX|995/21;566/21;452/21|G07.690.773.968.511
00000000|MMI|48.89|Fluorides|C0016327|[inch,phsu]|["F-"-tx-36-"f"-noun-0,"F-"-tx-16-"F"-adj-0,"F-"-tx-7-"F"-noun-0]|TX|4671/1;3374/1;2067/1|D01.248.497.158.380;D01.303.350.300
00000000|MMI|48.50|diagnosis aspect|C1704338|[qlco]|["diagnosis"-tx-7-"DIAGNOSIS"-noun-0]|TX|[1327/9],[1443/9]|x.x.x.x.x.x.x
00000000|MMI|45.77|Pravachol|C0700763|[orch,phsu]|["Pravachol"-tx-15-"pravachol"-noun-0,"Pravachol"-tx-6-"PRAVACHOL"-noun-0]|TX|2870/9;952/9|D02.455.426.559.847.638.930;D04.615.638.930
00000000|MMI|44.63|Pneumocystis jiroveci pneumonia|C1535939|[dsyn]|["PCP"-tx-21-"PCP"-noun-0,"PCP"-tx-15-"PCP"-noun-0,"PCP"-tx-7-"PCP"-noun-0]|TX|3667/3;3285/3;1993/3|C01.703.534.700;C01.703.770.700;C08.381.472.700;C08.381.677.675;C08.730.435.700;C08.730.610.675
00000000|MMI|42.15|Lasix|C0699992|[orch,phsu]|["Lasix"-tx-15-"lasix"-noun-0,"Lasix"-tx-3-"LASIX"-noun-0]|TX|2862/5;387/5|D02.065.884.725.300;D02.092.146.807.300;D02.886.590.700.725.300
00000000|MMI|41.27|Cauterization - action|C0007471|[topp]|["Cauterization"-tx-18-"cauterization"-noun-0,"cauterized"-tx-14-"cauterized"-verb-0,"cauterized"-tx-8-"cauterized"-verb-0,"Cauterization"-tx-7-"cauterization"-noun-0]|TX|3514/13;2669/10;2304/10;1932/13|E02.154;E04.014.170
00000000|MMI|40.34|To|C1883351|[qlco]|["To"-tx-35-"to"-adv-0,"To"-tx-24-"to"-adv-0,"To"-tx-21-"to"-adv-0,"To"-tx-15-"to"-adv-0,"To"-tx-11-"to"-adv-0,"To"-tx-8-"to"-adv-0,"To"-tx-7-"TO"-adv-0]|TX|4568/2;3884/2;3742/2;3304/2;2496/2;2262/2;1140/2|
00000000|MMI|40.22|Portugal|C0032729|[geoa]|["PO"-tx-6-"PO"-noun-0,"PO"-tx-4-"PO"-noun-0,"PO"-tx-3-"PO"-noun-0]|TX|984/2;[559/2],[650/2];414/2|Z01.542.727
00000000|MMI|39.52|Rabbi|C0684010|[prog]|["R."-tx-14-"R"-noun-0,"R."-tx-8-"R"-noun-0,"R."-tx-7-"R"-noun-0]|TX|2658/1;2282/1;1913/1|M01.526.799.500
00000000|MMI|39.35|Mongolia|C0026410|[geoa]|["MG"-tx-6-"MG"-noun-0,"MG"-tx-4-"MG"-noun-0,"MG"-tx-3-"MG"-noun-0]|TX|981/2;647/2;411/2|Z01.252.474.651
00000000|MMI|39.13|Protons|C0033727|[elii]|["H+"-tx-38-"H"-noun-0,"H+"-tx-4-"H"-noun-0]|TX|4778/1;779/1|D01.248.497.300.459.700;D01.268.406.750;D01.362.340.750;G01.249.765
00000000|MMI|35.81|Supraventricular tachycardia|C0039240|[dsyn]|["SUPRAVENTRICULAR TACHYCARDIA"-tx-7-"supraventricular tachycardia"-noun-0,"SVT"-tx-7-"svt"-noun-0]|TX|1569/28;1563/3|C14.280.067.845.880;C23.550.073.845.880
00000000|MMI|33.08|Folate|C0178638|[orch,phsu,vita]|["Folate"-tx-15-"folate"-noun-0,"Folate"-tx-4-"FOLATE"-noun-0]|TX|2853/6;623/6|D03.438.733.631.400
00000000|MMI|33.01|Data Validation Test Document|C3899446|[inpr]|["DVT"-tx-25-"DVT"-noun-0,"DVT"-tx-24-"DVT"-noun-0,"DVT"-tx-16-"DVT"-noun-0,"DVT"-tx-15-"DVT"-noun-0,"DVT"-tx-7-"DVT"-noun-0,"DVT"-tx-7-"dvt"-noun-0]|TX|[4017/3],[4072/3];[3871/3],[3978/3];3380/3;2703/3;2079/3;1764/3|
00000000|MMI|33.01|Ever told by doctor that you had deep venous thrombosis:Finding:Point in time:^Patient:Ordinal|C2926618|[clna]|["DVT"-tx-25-"DVT"-noun-0,"DVT"-tx-24-"DVT"-noun-0,"DVT"-tx-16-"DVT"-noun-0,"DVT"-tx-15-"DVT"-noun-0,"DVT"-tx-7-"DVT"-noun-0,"DVT"-tx-7-"dvt"-noun-0]|TX|[4017/3],[4072/3];[3871/3],[3978/3];3380/3;2703/3;2079/3;1764/3|
00000000|MMI|32.54|Dominican Republic|C0013014|[geoa]|["DR"-tx-26-"Dr"-noun-0,"DR"-tx-7-"Dr"-noun-0]|TX|4142/2;1223/2|Z01.107.084.900.300;Z01.639.880.300
00000000|MMI|32.49|Potassium Chloride|C0032825|[inch,phsu]|["POTASSIUM CHLORIDE"-tx-6-"POTASSIUM CHLORIDE"-noun-0]|TX|[822/18],[891/18]|D01.210.450.150.750;D01.745.625
00000000|MMI|32.35|Lebanon|C0023190|[geoa]|["LE"-tx-15-"LE"-noun-0,"LE"-tx-7-"LE"-noun-0]|TX|3061/2;1666/2|Z01.252.245.500.450
00000000|MMI|32.29|Saint Kitts and Nevis|C0282380|[geoa]|["SC"-tx-22-"SC"-noun-0,"SC"-tx-4-"SC"-noun-0]|TX|3854/2;679/2|Z01.107.084.900.787;Z01.639.880.787
00000000|MMI|30.42|Aspirin|C0004057|[orch,phsu]|["ASA"-tx-15-"asa"-noun-0]|TX|2818/3|D02.455.426.559.389.657.410.595.176
00000000|MMI|30.42|Citrus paradisi|C0947567|[plnt]|["grapefruit"-tx-6-"grapefruit"-noun-0]|TX|1035/10|B01.650.940.800.575.100.875.177.538
00000000|MMI|28.79|oncologist|C0259990|[prog]|["ONCOLOGIST"-tx-36-"oncologist"-noun-0,"ONCOLOGIST"-tx-34-"oncologist"-noun-0,"ONCOLOGIST"-tx-26-"oncologist"-noun-0,"ONCOLOGIST"-tx-21-"oncologist"-noun-0,"ONCOLOGIST"-tx-15-"oncologist"-noun-0,"ONCOLOGIST"-tx-7-"Oncologist"-noun-0]|TX|4680/10;4514/10;4131/10;[3719/10],[3785/10];3293/10;2014/10|
00000000|MMI|28.68|Obesity|C0028754|[dsyn]|["OBESE"-tx-15-"obese"-adj-0]|TX|2974/5|C18.654.726.500;C23.888.144.699.500;E01.370.600.115.100.160.120.699.500;G07.100.100.160.120.699.500
00000000|MMI|26.61|Diet|C0012155|[food]|["Diet"-tx-32-"diet"-noun-0,"Diet"-tx-7-"DIET"-noun-0]|TX|4379/4;1077/4|G07.203.650.240
00000000|MMI|26.61|Infantile Neuroaxonal Dystrophy|C0270724|[dsyn]|["PLAN"-tx-36-"PLAN"-noun-0,"PLAN"-tx-21-"plan"-noun-0]|TX|4633/4;3734/4|C10.228.140.744
00000000|MMI|26.20|Physicians|C0031831|[prog]|["DR"-tx-26-"Dr"-noun-0,"DR"-tx-7-"Dr"-noun-0]|TX|4142/2;1223/2|M01.526.485.810;N02.360.810
00000000|MMI|26.13|Panama|C0030266|[geoa]|["PM"-tx-40-"PM"-noun-0,"PM"-tx-1-"PM"-adj-0]|TX|4813/2;169/2|Z01.107.169.772
00000000|MMI|25.54|Heme|C0018966|[bacs,orch]|["Haem"-tx-29-"Heme"-noun-0]|TX|4217/4|D03.383.129.578.840.500.640.587;D03.549.909.500.640.587;D04.345.783.500.640.587;D23.767.727.640.587
00000000|MMI|24.11|Cerebroside-Sulfatase|C0007804|[aapp,enzy]|["ASA"-tx-15-"asa"-noun-0]|TX|2818/3|D08.811.277.352.827.070.250
00000000|MMI|24.11|Pravastatin|C0085542|[orch,phsu]|["PRAVASTATIN"-tx-6-"PRAVASTATIN"-noun-0]|TX|964/11|D02.455.426.559.847.638.930;D04.615.638.930
00000000|MMI|24.11|Surgical aspects|C0038895|[ftcn]|["operations"-tx-7-"OPERATIONS"-noun-0]|TX|1842/10|x.x.x.x.x.x.x
00000000|MMI|24.11|Warfarin|C0043031|[hops,orch,phsu]|["WARFARIN"-tx-33-"warfarin"-noun-0]|TX|4447/8|D03.383.663.283.446.520.914;D03.438.150.446.520.914
00000000|MMI|22.49|risk factors|C0035648|[qnco]|["Risk Factors"-tx-25-"risk factors"-noun-0]|TX|4000/12|E05.318.740.600.800.725;N05.715.350.200.700;N05.715.360.750.625.700.700;N06.850.490.625.750;N06.850.520.830.600.800.725
00000000|MMI|22.45|Chymosin C|C0008741|[aapp,bacs]|["Chymosin C"-tx-15-"labs c"-noun-0]|TX|3221/4,3231/1|D08.811.277.656.074.500.200;D08.811.277.656.300.048.200
00000000|MMI|22.35|Complement 3b Receptor|C0056182|[aapp,imft,rcpt]|["CR1"-tx-15-"cr1"-noun-0]|TX|3233/3|D12.776.543.750.705.833.600;D23.050.301.264.035.608;D23.101.100.110.608
00000000|MMI|22.35|therapeutic aspects|C0039798|[ftcn]|["treatment"-tx-7-"Treatment"-noun-0]|TX|1505/9|x.x.x.x.x.x.x
00000000|MMI|20.95|Furosemide|C0016860|[orch,phsu]|["FUROSEMIDE"-tx-3-"FUROSEMIDE"-noun-0]|TX|395/10|D02.065.884.725.300;D02.092.146.807.300;D02.886.590.700.725.300
00000000|MMI|20.95|Thrombophlebitis|C0040046|[dsyn]|["THROMBOPHLEBITIS"-tx-7-"thrombophlebitis"-noun-0]|TX|1600/16|C14.907.355.830.925.770;C14.907.617.718.788;C14.907.940.740.910
00000000|MMI|20.95|Vision|C0042789|[orgf]|["sees"-tx-21-"sees"-verb-0]|TX|3776/4|F02.830.816.964;G02.111.087.800.480.900;G02.149.115.800.480.900;G04.299.880.480.900;G11.561.600.810.964;G14.640.816
00000000|MMI|20.55|Educational process of instructing|C0039401|[edac]|["Instruction"-tx-6-"Instruction"-noun-0,"Instruction"-tx-4-"Instruction"-noun-0,"Instruction"-tx-3-"Instruction"-noun-0]|TX|1017/11;588/11;474/11|I02.903
00000000|MMI|20.30|Disease|C0012634|[dsyn]|["condition"-tx-36-"CONDITION"-noun-0,"condition"-tx-7-"Conditions"-noun-0]|TX|4609/9;1453/10|C23.550.288
00000000|MMI|20.30|Hypertensive disease|C0020538|[dsyn]|["HTN"-tx-7-"htn"-noun-0,"HYPERTENSION"-tx-7-"hypertension"-noun-0]|TX|1542/3;1548/12|C14.907.489
00000000|MMI|20.26|Diet therapy|C0012159|[hlca]|["Diet"-tx-32-"diet"-noun-0,"Diet"-tx-7-"DIET"-noun-0]|TX|4379/4;1077/4|E02.642.249
00000000|MMI|20.02|Atrial Fibrillation by ECG Finding|C0344434|[lbtr]|["AF"-tx-15-"AF"-noun-0,"AFib"-tx-15-"Afib"-noun-0,"AFib"-tx-7-"Afib"-noun-0,"AFib"-tx-7-"afib"-noun-0,"Atrial Fibrillation"-tx-7-"atrial fibrillation"-noun-0]|TX|2951/2;2721/4;2097/4;1735/4;1742/19|
00000000|MMI|19.45|Axis vertebra|C0004457|[bpoc]|["Axis"-tx-15-"axis"-noun-0]|TX|3167/4|A02.835.232.834.151.383
00000000|MMI|19.36|Nicotinamide adenine dinucleotide (NAD)|C0027270|[bacs,nnon,phsu]|["NAD+"-tx-15-"NAD"-noun-0]|TX|2982/3|D03.438.759.646.138.694;D08.211.589;D13.695.667.138.694;D13.695.827.068.694
00000000|MMI|19.36|Meal (occasion for eating)|C1998602|[dora]|["Meals"-tx-3-"meals"-noun-0]|TX|509/5|F01.145.407.432.500;F01.145.466.349.500;G07.203.300.590;G07.203.650.353.432.500;J02.500.590
00000000|MMI|19.31|District of Columbia|C0012764|[geoa]|["D.C."-tx-1-"D/C"-noun-0]|TX|214/3|Z01.107.567.875.500.210;Z01.433.429
00000000|MMI|19.27|3,4-Methylenedioxyamphetamine|C0000379|[orch,phsu]|["MDA"-tx-6-"MDA"-noun-0]|TX|948/3|D02.092.471.683.152.660
00000000|MMI|19.22|Acebutolol|C0000946|[orch,phsu]|["ACEBUTOLOL"-tx-3-"ACEBUTOLOL"-noun-0]|TX|423/10|D02.033.100.624.698.025;D02.033.755.624.698.025;D02.092.063.624.698.025
00000000|MMI|19.09|Stop (qualifier value)|C2746065|[tmco]|["End"-tx-40-"END"-noun-0,"Stop"-tx-36-"Stop"-noun-0,"Stop"-tx-34-"stop"-verb-0,"Stop"-tx-33-"stop"-noun-0,"Stop"-tx-21-"stop"-verb-0]|TX|4823/3;4639/4;4464/4;4425/4;3745/4|
00000000|MMI|17.80|Electrocardiography|C1623258|[diap]|["ECG NOS"-tx-15-"ECG"-noun-0]|TX|3128/3|E01.370.370.380.240;E01.370.405.240
00000000|MMI|17.80|Folic Acid|C0016410|[orch,phsu,vita]|["FOLIC ACID"-tx-4-"FOLIC ACID"-noun-0]|TX|632/10|D03.438.733.631.400
00000000|MMI|17.80|Milk (body substance)|C0026131|[bdsu]|["MILK"-tx-4-"milk"-noun-0]|TX|606/4|A12.200.455;G07.203.100.700;G07.203.300.350.525;J02.200.700;J02.500.350.525
00000000|MMI|16.34|Fat-Restricted Diet|C0242970|[topp]|["Low fat diet, NOS"-tx-7-"Low fat DIET"-noun-0]|TX|1091/3,1109/8|E02.642.249.260;G07.203.650.240.260
00000000|MMI|16.30|Saint Lucia|C0036056|[geoa]|["ST"-tx-15-"ST"-noun-0]|TX|3183/2|Z01.107.084.900.825;Z01.639.880.825
00000000|MMI|16.18|Treatment Protocols|C0040808|[topp]|["Regimen"-tx-15-"regimen"-noun-0]|TX|3342/7|E02.183;N05.715.360.775.225
00000000|MMI|16.12|Antacids|C0003138|[phsu]|["Antacid"-tx-4-"antacid"-noun-0]|TX|615/7|D27.505.519.170;D27.505.954.483.080
00000000|MMI|16.12|Anti-Ulcer Agent|C0003216|[phsu]|["Antacid"-tx-4-"antacid"-noun-0]|TX|615/7|D27.505.954.483.203
00000000|MMI|16.04|Dizziness|C0012833|[sosy]|["Lightheadedness"-tx-10-"lightheadedness"-noun-0]|TX|2465/15|C10.597.751.237;C23.888.592.763.237
00000000|MMI|16.04|Lightheadedness|C0220870|[sosy]|["LIGHTHEADEDNESS"-tx-10-"lightheadedness"-noun-0]|TX|2465/15|C10.597.751.237;C23.888.592.763.237
00000000|MMI|15.79|Doctor of Medicine|C1512018|[inpr]|["M.D."-tx-39-"M.D"-noun-0,"M.D."-tx-5-"M.D"-noun-0,"M.D."-tx-1-"M.D"-noun-0]|TX|4783/3;784/3;299/3|
00000000|MMI|15.79|Schedule (document type)|C0086960|[inpr]|["Scheduled"-tx-7-"scheduled"-verb-0]|TX|[1211/9],[1252/9],[1275/9]|
00000000|MMI|15.79|Scheduled - priority|C1571999|[qlco]|["Scheduled"-tx-7-"scheduled"-verb-0]|TX|[1211/9],[1252/9],[1275/9]|
00000000|MMI|15.79|Scheduled - procedure status|C0205539|[qlco]|["Scheduled"-tx-7-"scheduled"-verb-0]|TX|[1211/9],[1252/9],[1275/9]|
00000000|MMI|15.07|Integrated Neuromusculoskeletal Release|C1704538|[topp]|["INR"-tx-19-"INR"-noun-0,"INR"-tx-15-"INR"-noun-0,"INR"-tx-12-"INR"-noun-0]|TX|3584/3;[3109/3],[3252/3];2560/3|
00000000|MMI|15.04|Stop (Instruction Imperative)|C1947925|[acty]|["Stop"-tx-36-"Stop"-noun-0,"Stop"-tx-34-"stop"-verb-0,"Stop"-tx-33-"stop"-noun-0,"Stop"-tx-21-"stop"-verb-0]|TX|4639/4;4464/4;4425/4;3745/4|
00000000|MMI|14.80|+2|C0740116|[qnco]|["+2"-tx-35-"2"-fraction-0,"+2"-tx-23-"2"-integer-0,"+2"-tx-15-"2"-fraction-0,"+2"-tx-7-"2"-integer-0]|TX|4564/1;3864/1;3007/1;1119/1|
00000000|MMI|14.80|2+|C3833492|[fndg]|["2+"-tx-35-"2"-fraction-0,"2+"-tx-23-"2"-integer-0,"2+"-tx-15-"2"-fraction-1,"2+"-tx-7-"2"-integer-0]|TX|4564/1;3864/1;3007/1;1119/1|
00000000|MMI|14.80|2+ Score|C2827735|[qnco]|["2+"-tx-35-"2"-fraction-0,"2+"-tx-23-"2"-integer-0,"2+"-tx-15-"2"-fraction-0,"2+"-tx-7-"2"-integer-0]|TX|4564/1;3864/1;3007/1;1119/1|
00000000|MMI|14.80|2+ Score, WHO|C2981700|[clas]|["2+"-tx-35-"2"-fraction-0,"2+"-tx-23-"2"-integer-0,"2+"-tx-15-"2"-fraction-0,"2+"-tx-7-"2"-integer-0]|TX|4564/1;3864/1;3007/1;1119/1|
00000000|MMI|14.75|NOSEBLEED QR KIT|C2724883|[drdd]|["NOSEBLEED"-tx-20-"nose bleed"-noun-0,"NOSEBLEED"-tx-16-"nosebleeds"-noun-0,"NOSEBLEED"-tx-9-"nosebleed"-noun-0,"NOSEBLEED"-tx-7-"nosebleed"-noun-0]|TX|3641/10;3483/10;2374/9;1950/9|
00000000|MMI|14.70|NT5E wt Allele|C3889152|[gngm]|["eNT"-tx-18-"ENT"-noun-0,"eNT"-tx-14-"ENT"-noun-0,"eNT"-tx-8-"ENT"-noun-0,"eNT"-tx-7-"ENT"-noun-0]|TX|3531/3;2623/3;2228/3;1264/3|
00000000|MMI|14.64|Awareness|C0004448|[menp]|["Aware"-tx-27-"aware"-adj-0]|TX|4153/5|F02.463.188.150
00000000|MMI|14.64|Consultation|C0009818|[hlca]|["consulted"-tx-14-"consulted"-verb-0]|TX|2631/9|N04.452.758.849
00000000|MMI|14.64|Desiccation|C0011682|[npop]|["Dry"-tx-35-"dry"-verb-0]|TX|4594/3|E05.196.335;G02.149.767.530;G02.842.750.530
00000000|MMI|14.64|Recurrence|C0034897|[phpr]|["Recurrence"-tx-18-"recurrence"-noun-0]|TX|3543/10|C23.550.291.937
00000000|MMI|14.64|Recurrence (disease attribute)|C2825055|[patf]|["Recurrence"-tx-18-"recurrence"-noun-1]|TX|3543/10|C23.550.291.937
00000000|MMI|14.64|Wound Healing|C0043240|[orgf]|["heal"-tx-20-"heal"-verb-0]|TX|3661/4|G16.100.856.891
00000000|MMI|14.62|Body Fluid Discharge|C0012621|[bdsu]|["Discharge"-tx-40-"DISCHARGE"-noun-0,"Discharge"-tx-36-"DISCHARGE"-noun-0,"Discharge"-tx-7-"DISCHARGE"-noun-0,"Discharge"-tx-1-"DISCHARGE"-noun-0]|TX|4830/9;4599/9;1358/9;38/9|
00000000|MMI|14.62|Discharge, body substance|C2926602|[bdsu]|["Discharge"-tx-40-"DISCHARGE"-noun-0,"Discharge"-tx-36-"DISCHARGE"-noun-0,"Discharge"-tx-7-"DISCHARGE"-noun-0,"Discharge"-tx-1-"DISCHARGE"-noun-0]|TX|4830/9;4599/9;1358/9;38/9|
00000000|MMI|14.61|Beginning|C0439659|[tmco]|["Start"-tx-37-"Start"-noun-0,"Start"-tx-35-"starting"-verb-0,"Start"-tx-27-"starting"-adj-0,"Start"-tx-22-"start"-noun-0]|TX|4692/5;4555/8;4196/8;3831/5|
00000000|MMI|14.24|Daily|C0332173|[tmco]|["Daily"-tx-22-"daily"-adv-0,"Daily"-tx-15-"Daily"-adj-0,"Daily"-tx-4-"DAILY"-adj-0,"Daily"-tx-3-"DAILY"-adj-0]|TX|3857/5;3271/5;653/5;417/5|
00000000|MMI|14.23|Magnesium Cation|C2346927|[elii,phsu]|["Mg++"-tx-6-"MG"-noun-0,"Mg++"-tx-4-"MG"-noun-0,"Mg+2"-tx-4-"MG 2"-noun-0,"Mg++"-tx-3-"MG"-noun-0]|TX|981/2;647/2;647/2,672/1;411/2|
00000000|MMI|14.22|Oral|C0442027|[spco]|["PO"-tx-6-"PO"-noun-0,"PO"-tx-4-"PO"-noun-0,"PO"-tx-3-"PO"-noun-0]|TX|984/2;[559/2],[650/2];414/2|
00000000|MMI|13.09|Sodium|C0037473|[bacs,elii]|["SODIUM"-tx-7-"Sodium"-noun-0]|TX|1126/6|D01.268.549.750;D01.268.557.650;D01.552.528.850;D01.552.547.725;x.x.x.x
00000000|MMI|13.06|Leukocytes|C0023516|[cell]|["WBC"-tx-15-"wbc"-noun-0]|TX|3089/3|A11.118.637;A15.145.229.637;A15.382.490
00000000|MMI|13.05|Nose|C0028429|[bpoc]|["NOSE"-tx-35-"nose"-noun-0]|TX|4576/4|A01.456.505.733;A04.531;A09.531
00000000|MMI|13.05|Rales|C0034642|[sosy]|["Crackles"-tx-15-"crackles"-verb-1]|TX|3022/8|C23.888.852.779;E01.370.386.720;G09.772.775
00000000|MMI|13.03|Stomach|C0038351|[bpoc]|["STOMACH"-tx-3-"stomach"-noun-0]|TX|527/7|A03.556.875.875
00000000|MMI|13.00|Dilatation and Curettage|C0012358|[topp]|["D & C"-tx-1-"D/C"-noun-0]|TX|214/3|E04.157.310;E04.950.300.299
00000000|MMI|12.96|Moldova|C0026374|[geoa]|["MDA"-tx-6-"MDA"-noun-0]|TX|948/3|Z01.542.248.540;Z01.586.200.540;Z01.586.950.540
00000000|MMI|12.94|Rehabilitation therapy|C0034991|[topp]|["Rehabilitation"-tx-3-"Rehabilitation"-noun-0]|TX|349/14|E02.831;H02.403.680.600;N02.421.784
00000000|MMI|12.92|PO-2|C0297199|[orch]|["PO-2"-tx-4-"PO 2"-noun-0]|TX|650/2,672/1|x.x.x.x
00000000|MMI|12.91|fondaparinux|C1098510|[orch,phsu]|["FONDAPARINUX"-tx-4-"FONDAPARINUX"-noun-0]|TX|659/12|x.x.x.x
00000000|MMI|12.89|Evaluation|C0220825|[hlca]|["Evaluation"-tx-1-"evaluation"-noun-0]|TX|198/10|E05.337;N05.715.360.335
00000000|MMI|12.89|doxorubicin/mitomycin/vinblastine protocol|C0052712|[topp]|["MVA"-tx-7-"MVA"-noun-0]|TX|1524/3|x.x.x.x
00000000|MMI|11.92|Hospital admission|C0184666|[hlca]|["Admit"-tx-15-"admit"-verb-0,"Admission"-tx-7-"Admission"-noun-0,"Admit"-tx-7-"ADMIT"-verb-0]|TX|2800/5;1415/9;1321/5|
00000000|MMI|11.79|Order (action)|C1705178|[acty]|["Order"-tx-40-"ORDERS"-verb-0,"Order"-tx-1-"ORDER"-noun-0,"Order"-tx-1-"ORDERS"-verb-0]|TX|4840/6;218/5;48/6|
00000000|MMI|11.79|Order (arrangement)|C1705176|[qlco]|["Order"-tx-40-"ORDERS"-verb-0,"Order"-tx-1-"ORDER"-noun-0,"Order"-tx-1-"ORDERS"-verb-0]|TX|4840/6;218/5;48/6|
00000000|MMI|11.79|Order (document)|C1705175|[inpr]|["Order"-tx-40-"ORDERS"-verb-0,"Order"-tx-1-"ORDER"-noun-0,"Order"-tx-1-"ORDERS"-verb-0]|TX|4840/6;218/5;48/6|
00000000|MMI|11.79|Order (taxonomic)|C1705177|[clas]|["Order"-tx-40-"ORDERS"-verb-0,"Order"-tx-1-"ORDER"-noun-0,"Order"-tx-1-"ORDERS"-verb-0]|TX|4840/6;218/5;48/6|
00000000|MMI|11.79|Permutation|C1882348|[qlco]|["Order"-tx-40-"ORDERS"-verb-0,"Order"-tx-1-"ORDER"-noun-0,"Order"-tx-1-"ORDERS"-verb-0]|TX|4840/6;218/5;48/6|
00000000|MMI|11.79|Sequence of Planned Assessment Schedule|C3889825|[inpr]|["ORDER"-tx-40-"ORDERS"-verb-0,"ORDER"-tx-1-"ORDER"-noun-0,"ORDER"-tx-1-"ORDERS"-verb-0]|TX|4840/6;218/5;48/6|
00000000|MMI|11.60|Present|C0150312|[qnco]|["Present"-tx-16-"presents"-verb-0,"Found"-tx-8-"found"-verb-0,"Present"-tx-7-"presents"-verb-0]|TX|3458/8;2256/5;2169/8|
00000000|MMI|11.55|Override|C1547671|[acty]|["Override"-tx-6-"override"-verb-0,"Override"-tx-4-"Override"-verb-0,"Override"-tx-4-"overridden"-noun-0]|TX|938/8;732/8;720/10|
00000000|MMI|11.49|Allergy Specialty|C0002111|[bmod]|["Allergy"-tx-7-"ALLERGY"-noun-0]|TX|1287/7|H02.403.044
00000000|MMI|11.49|Complication Aspects|C1171258|[patf]|["complications"-tx-7-"Complications"-noun-0]|TX|1479/13|x.x.x
00000000|MMI|11.49|Methods aspects|C0025664|[inpr]|["procedures"-tx-7-"PROCEDURES"-noun-0]|TX|1857/10|x.x.x
00000000|MMI|11.32|Transfused|C1549003|[idcn]|["Transfused"-tx-31-"transfused"-verb-0,"Transfused"-tx-29-"transfused"-adj-0,"Transfused"-tx-13-"transfused"-verb-0]|TX|4321/10;4224/10;2591/10|
00000000|MMI|10.94|Instruction [Publication Type]|C0302828|[inpr]|["Instruction"-tx-6-"Instruction"-noun-0,"Instruction"-tx-4-"Instruction"-noun-0,"Instruction"-tx-3-"Instruction"-noun-0]|TX|1017/11;588/11;474/11|
00000000|MMI|10.94|Instructions|C1442085|[idcn]|["instruction"-tx-6-"Instruction"-noun-0,"instruction"-tx-4-"Instruction"-noun-0,"instruction"-tx-3-"Instruction"-noun-0]|TX|1017/11;588/11;474/11|
00000000|MMI|10.86|Endocrine System Findings Domain|C3538926|[idcn]|["ED"-tx-11-"ED"-noun-0,"ED"-tx-9-"ED"-noun-0,"ED"-tx-8-"ED"-noun-0]|TX|2512/2;2404/2;2239/2|
00000000|MMI|10.85|Take|C1515187|[hlca]|["Take"-tx-34-"taking"-adj-0,"Take"-tx-33-"taking"-adj-0,"Take"-tx-3-"Take"-verb-0]|TX|4469/6;4430/6;486/4|
00000000|MMI|10.79|Anterior nares|C0595944|[bsoj]|["nare"-tx-14-"nare"-noun-0,"nare"-tx-8-"nare"-noun-0,"nare"-tx-7-"nare"-noun-0]|TX|2660/4;2284/4;1927/4|
00000000|MMI|10.79|Excision|C0728940|[topp]|["Resection"-tx-16-"resection"-noun-0,"Resection"-tx-15-"resection"-noun-0,"Resection"-tx-7-"resection"-noun-0]|TX|3420/9;2750/9;2126/9|
00000000|MMI|10.79|removal technique|C0015252|[topp]|["resection"-tx-16-"resection"-noun-0,"resection"-tx-15-"resection"-noun-0,"resection"-tx-7-"resection"-noun-0]|TX|3420/9;2750/9;2126/9|
00000000|MMI|10.68|R prime|C2603358|[clna]|["R'"-tx-14-"R"-noun-0,"R'"-tx-8-"R"-noun-0,"R'"-tx-7-"R"-noun-0]|TX|2658/1;2282/1;1913/1|
00000000|MMI|10.68|Right|C0205090|[spco]|["R-"-tx-14-"R"-noun-0,"R-"-tx-8-"R"-noun-0,"R-"-tx-7-"R"-noun-0]|TX|2658/1;2282/1;1913/1|
00000000|MMI|10.64|Arixtra|C1099665|[orch,phsu]|["Arixtra"-tx-37-"Arixtra"-noun-0,"Arixtra"-tx-27-"arixtra"-noun-0,"Arixtra"-tx-22-"Arixtra"-noun-0]|TX|4719/7;4205/7;3840/7|
00000000|MMI|10.62|history of - * (non-specific)|C0455483|[fndg]|["h o"-tx-25-"h/o"-noun-0,"h o"-tx-24-"h/o"-noun-0,"h o"-tx-16-"o h"-noun-0]|TX|4068/3;3867/3;3372/1,3376/1|
00000000|MMI|10.61|Code|C0805701|[inpr]|["CODE"-tx-33-"code"-noun-0,"CODE"-tx-3-"CODE"-noun-0,"CODE"-tx-3-"code"-noun-0]|TX|4392/4;313/4;331/4|
00000000|MMI|10.61|eTMF Content Model Code|C3889831|[inpr]|["Code"-tx-33-"code"-noun-0,"Code"-tx-3-"CODE"-noun-0,"Code"-tx-3-"code"-noun-0]|TX|4392/4;313/4;331/4|
00000000|MMI|10.60|ANTICOAGULATION (finding)|C2919015|[fndg]|["ANTICOAGULATION"-tx-37-"anticoagulation"-noun-0,"ANTICOAGULATION"-tx-25-"anticoagulation"-noun-0,"ANTICOAGULATION"-tx-15-"anticoagulation"-noun-0]|TX|4698/15;4109/15;3326/15|
00000000|MMI|10.60|Anticoagulation Therapy|C0003281|[topp]|["anticoagulation"-tx-37-"anticoagulation"-noun-0,"anticoagulation"-tx-25-"anticoagulation"-noun-0,"anticoagulation"-tx-15-"anticoagulation"-noun-0]|TX|4698/15;4109/15;3326/15|
00000000|MMI|10.60|Decreased Coagulation Activity [PE]|C3537050|[phsf]|["Anticoagulation"-tx-37-"anticoagulation"-noun-0,"Anticoagulation"-tx-25-"anticoagulation"-noun-0,"Anticoagulation"-tx-15-"anticoagulation"-noun-0]|TX|4698/15;4109/15;3326/15|
00000000|MMI|10.60|Negative Regulation of Coagulation|C2917212|[phsf]|["Anticoagulation"-tx-37-"anticoagulation"-noun-0,"Anticoagulation"-tx-25-"anticoagulation"-noun-0,"Anticoagulation"-tx-15-"anticoagulation"-noun-0]|TX|4698/15;4109/15;3326/15|
00000000|MMI|10.57|Pharmacogenomics Trial Characteristics Domain|C3714755|[inpr]|["PT"-tx-26-"Pt's"-noun-0,"PT"-tx-21-"pt's"-noun-0,"PT"-tx-15-"pt"-noun-0]|TX|4126/4;3714/4;3354/2|
00000000|MMI|10.57|Physical therapy (field)|C0699718|[bmod]|["PT"-tx-26-"Pt's"-noun-0,"PT"-tx-21-"pt's"-noun-0,"PT"-tx-15-"pt"-noun-0]|TX|4126/4;3714/4;3354/2|
00000000|MMI|10.53|Anterior|C0205094|[ftcn]|["ANTERIOR"-tx-14-"anterior"-adj-0,"ANTERIOR"-tx-8-"anterior"-adj-0,"ANTERIOR"-tx-7-"anterior"-adj-0]|TX|2649/8;2273/8;1918/8|
00000000|MMI|10.51|Non-small cell|C0445128|[qlco]|["Non-small cell"-tx-16-"non-small cell"-noun-0,"Non-small cell"-tx-15-"non-small cell"-noun-0,"Non-small cell"-tx-7-"non-small cell"-noun-0]|TX|3398/14;2728/14;2104/14|
00000000|MMI|10.51|20%|C3842589|[fndg]|["20%"-tx-15-"20"-integer-0,"20%"-tx-6-"20"-integer-0,"20%"-tx-4-"20"-integer-0]|TX|2964/2;978/2;699/2|
00000000|MMI|10.51|Milligram percent|C1960952|[qnco]|["mg %"-tx-6-"MG"-noun-0,"mg %"-tx-4-"MG"-noun-0,"mg %"-tx-3-"MG"-noun-0]|TX|981/2;647/2;411/2|
00000000|MMI|10.51|mg/dL|C0439269|[qnco]|["mg%"-tx-6-"MG"-noun-0,"mg%"-tx-4-"MG"-noun-0,"mg%"-tx-3-"MG"-noun-0]|TX|981/2;647/2;411/2|
00000000|MMI|10.42|Diagnosis|C0011900|[fndg]|["DIAGNOSIS"-tx-7-"DIAGNOSIS"-noun-0]|TX|[1327/9],[1443/9]|E01
00000000|MMI|10.42|Diagnosis Study|C1704656|[resa]|["DIAGNOSIS"-tx-7-"DIAGNOSIS"-noun-0]|TX|[1327/9],[1443/9]|
00000000|MMI|10.42|Percocet|C0086787|[orch,phsu]|["Percocet"-tx-15-"percocet"-noun-0,"Percocet"-tx-7-"PERCOCET"-noun-0]|TX|2904/8;1296/8|
00000000|MMI|10.42|Supraventricular Tachycardia by ECG Finding|C3815188|[fndg]|["SVT"-tx-7-"svt"-noun-0,"Supraventricular Tachycardia"-tx-7-"supraventricular tachycardia"-noun-0]|TX|1563/3;1569/28|
00000000|MMI|10.42|orders - HL7PublishingDomain|C3244315|[inpr]|["orders"-tx-40-"ORDERS"-verb-0,"orders"-tx-1-"ORDERS"-verb-0]|TX|4840/6;48/6|
00000000|MMI|9.99|Ambulatory Care Facilities|C0002424|[hcro,mnob]|["Clinic"-tx-7-"clinic"-noun-0]|TX|1268/6|N02.278.035
00000000|MMI|9.91|Appointments|C0003629|[idcn]|["Appointment"-tx-7-"APPOINTMENT"-noun-0]|TX|1174/11|N04.452.095
00000000|MMI|9.91|Edema|C0013604|[fndg]|["OEDEMA"-tx-15-"edema"-noun-0]|TX|3064/5|C23.888.277
00000000|MMI|9.90|Communication|C0009452|[socb]|["COMMUNICATION"-tx-21-"communication"-noun-0]|TX|3691/13|F01.145.209;L01.143
00000000|MMI|9.87|Back|C0004600|[blor]|["BACK"-tx-24-"back"-adj-0]|TX|3916/4|A01.923.176
00000000|MMI|9.81|Christianity|C0008532|[idcn]|["Christian"-tx-1-"CHRISTIAN"-noun-0]|TX|281/9|K01.844.188
00000000|MMI|9.81|Netherlands|C0027778|[geoa]|["NL"-tx-15-"nl"-noun-0]|TX|3164/2|Z01.542.651
00000000|MMI|9.78|Rehabilitation aspects|C0034992|[ftcn]|["Rehabilitation"-tx-3-"Rehabilitation"-noun-0]|TX|349/14|x.x.x
00000000|MMI|9.77|utilization qualifier|C0042153|[ftcn]|["use"-tx-35-"use"-noun-0]|TX|4533/3|x.x.x
00000000|MMI|9.77|Abdomen|C0000726|[blor]|["abd"-tx-15-"abd"-adj-0]|TX|3042/3|A01.923.047
00000000|MMI|8.34|Allergic Reaction|C1527304|[patf]|["Allergy"-tx-7-"ALLERGY"-noun-0]|TX|1287/7|C20.543
00000000|MMI|8.34|Hypersensitivity|C0020517|[patf]|["ALLERGY"-tx-7-"ALLERGY"-noun-0]|TX|1287/7|C20.543
00000000|MMI|8.34|Infection|C3714514|[patf]|["Infections"-tx-7-"Infections"-noun-0]|TX|1466/10|C01.539
00000000|MMI|8.34|Work|C0043227|[ocac]|["Work"-tx-7-"WORK"-verb-0]|TX|1143/4|I03.946
00000000|MMI|7.61|Condition|C0348080|[qlco]|["Condition"-tx-36-"CONDITION"-noun-0,"Condition"-tx-7-"Conditions"-noun-0]|TX|4609/9;1453/10|
00000000|MMI|7.61|Condition:Find:Pt:^Patient:Nom|C3864998|[clna]|["Condition"-tx-36-"CONDITION"-noun-0,"Condition"-tx-7-"Conditions"-noun-0]|TX|4609/9;1453/10|
00000000|MMI|7.61|Logical Condition|C1705253|[cnce]|["Condition"-tx-36-"CONDITION"-noun-0,"Condition"-tx-7-"Conditions"-noun-0]|TX|4609/9;1453/10|
00000000|MMI|7.57|Basal Diet|C2983588|[food]|["DIET"-tx-32-"diet"-noun-0,"DIET"-tx-7-"DIET"-noun-0]|TX|4379/4;1077/4|
00000000|MMI|7.57|Diet (animal life circumstance)|C3668949|[food]|["Diet"-tx-32-"diet"-noun-0,"Diet"-tx-7-"DIET"-noun-0]|TX|4379/4;1077/4|
00000000|MMI|7.57|Planned|C1301732|[ftcn]|["Plan"-tx-36-"PLAN"-noun-0,"Plan"-tx-21-"plan"-noun-0]|TX|4633/4;3734/4|
00000000|MMI|7.57|Special Diet Therapy|C1519433|[topp]|["DIET"-tx-32-"diet"-noun-0,"DIET"-tx-7-"DIET"-noun-0]|TX|4379/4;1077/4|
00000000|MMI|7.57|Treatment Plan|C0599880|[inpr]|["Plan"-tx-36-"PLAN"-noun-0,"Plan"-tx-21-"plan"-noun-0]|TX|4633/4;3734/4|
00000000|MMI|7.49|Presentation|C0449450|[idcn]|["Present"-tx-16-"presents"-verb-0,"Present"-tx-7-"presents"-verb-0]|TX|3458/8;2169/8|
00000000|MMI|7.44|Medical History|C0262926|[fndg]|["PMH"-tx-15-"PMH"-noun-0,"PMH"-tx-7-"PMH"-noun-0]|TX|2698/3;2072/3|
00000000|MMI|7.40|/hour|C0564385|[qnco]|["/h"-tx-38-"H"-noun-0,"/h"-tx-4-"H"-noun-0]|TX|4778/1;779/1|
00000000|MMI|7.40|H NOS Antibodies|C0369286|[aapp,imft]|["H NOS"-tx-38-"H"-noun-0,"H NOS"-tx-4-"H"-noun-0]|TX|4778/1;779/1|
00000000|MMI|7.40|Hepatic Involvement|C0441932|[clas]|["H+"-tx-38-"H"-noun-0,"H+"-tx-4-"H"-noun-0]|TX|4778/1;779/1|
00000000|MMI|7.29|Interaction|C1704675|[ftcn]|["Interaction"-tx-6-"INTERACTION"-noun-0]|TX|[809/11],[878/11]|
00000000|MMI|7.28|Home environment|C0442519|[cnce]|["HOME"-tx-8-"home"-noun-0,"house"-tx-7-"House"-noun-0]|TX|2332/4;1083/5|
00000000|MMI|7.26|Summary (document)|C1706244|[inpr]|["Summary"-tx-38-"summary"-noun-0,"Summary"-tx-1-"SUMMARY"-noun-0]|TX|4740/7;243/7|
00000000|MMI|7.26|summary - ActRelationshipSubset|C1552616|[inpr]|["summary"-tx-38-"summary"-noun-0,"summary"-tx-1-"SUMMARY"-noun-0]|TX|4740/7;243/7|
00000000|MMI|7.23|S prime|C2603362|[clna]|["S'"-tx-18-"s"-prep-0,"S'"-tx-7-"("-noun-0]|TX|3510/1;1185/1|
00000000|MMI|7.23|per second|C0565930|[qnco]|["/s"-tx-18-"s"-prep-0,"/s"-tx-7-"("-noun-0]|TX|3510/1;1185/1|
00000000|MMI|7.20|Medical Examination|C0582103|[hlca]|["Exam"-tx-15-"Exam"-noun-0,"Exam"-tx-15-"exam"-noun-0]|TX|2933/4;3198/4|
00000000|MMI|7.16|Delayed Release Dosage Form|C1707664|[bodm]|["DR"-tx-26-"Dr"-noun-0,"DR"-tx-7-"Dr"-noun-0]|TX|4142/2;1223/2|
00000000|MMI|7.16|Device to Subject Relationship Domain|C3540849|[inpr]|["DR"-tx-26-"Dr"-noun-0,"DR"-tx-7-"Dr"-noun-0]|TX|4142/2;1223/2|
00000000|MMI|7.16|Doctor - Title|C2348314|[cnce]|["Dr."-tx-26-"Dr"-noun-0,"Dr."-tx-7-"Dr"-noun-0]|TX|4142/2;1223/2|
00000000|MMI|7.11|Negation|C1518422|[ftcn]|["Not"-tx-15-"not"-adv-0,"Not"-tx-7-"NOT"-adv-0]|TX|2986/3;1904/3|
00000000|MMI|7.11|Clinical Study Follow-up|C3274571|[hlca]|["FOLLOW-UP"-tx-34-"follow up"-adj-0,"FOLLOW-UP"-tx-7-"FOLLOW UP"-adj-0]|TX|4494/9;1164/9|
00000000|MMI|7.11|Follow-Up Report|C1704685|[inpr]|["Follow-Up"-tx-34-"follow up"-adj-0,"Follow-Up"-tx-7-"FOLLOW UP"-adj-0]|TX|4494/9;1164/9|
00000000|MMI|7.11|Follow-up status|C0589120|[fndg]|["Follow-up"-tx-34-"follow up"-adj-0,"Follow-up"-tx-7-"FOLLOW UP"-adj-1]|TX|4494/9;1164/9|
00000000|MMI|7.11|follow-up|C1522577|[hlca]|["Follow Up"-tx-34-"follow up"-adj-0,"Follow Up"-tx-7-"FOLLOW UP"-adj-0]|TX|4494/9;1164/9|
00000000|MMI|7.09|Attending (action)|C1999232|[ftcn]|["attending"-tx-1-"Attending"-adj-0,"attending"-tx-1-"Attending"-noun-0]|TX|[188/9],[256/9];[188/9],[256/9]|
00000000|MMI|7.09|Attending (provider role)|C1547429|[prog]|["Attending"-tx-1-"Attending"-adj-0,"Attending"-tx-1-"Attending"-noun-0]|TX|[188/9],[256/9];[188/9],[256/9]|
00000000|MMI|7.09|Fresh frozen plasma|C0016709|[bdsu]|["FFP"-tx-19-"FFP"-noun-0,"FFP"-tx-13-"FFP"-noun-0]|TX|3575/3;2618/3|
00000000|MMI|7.09|Infusion pump Alert priority PM|C4049155|[fndg]|["PM"-tx-40-"PM"-noun-0,"PM"-tx-1-"PM"-adj-0]|TX|4813/2;169/2|
00000000|MMI|7.08|Patient Condition Code - Stable|C1547311|[inpr]|["Stable"-tx-36-"Stable"-adj-0,"Stable"-tx-30-"stable"-adj-0]|TX|4620/6;4298/6|
00000000|MMI|7.08|Stable status|C0205360|[qlco]|["STABLE"-tx-36-"Stable"-adj-0,"STABLE"-tx-30-"stable"-adj-0]|TX|4620/6;4298/6|
00000000|MMI|7.08|persistent|C0205322|[tmco]|["Persistent"-tx-16-"persistent"-adj-0,"Persistent"-tx-7-"persistent"-adj-0]|TX|3472/10;2181/10|
00000000|MMI|7.06|60%|C3842585|[fndg]|["60%"-tx-15-"60s"-noun-0,"60%"-tx-10-"60"-integer-0]|TX|3136/3;2439/2|
00000000|MMI|7.03|Axial R|C3538806|[spco]|["Ra"-tx-15-"RA"-noun-0,"Ra"-tx-10-"RA"-noun-0]|TX|2971/2;2452/2|
00000000|MMI|7.03|Right arm|C4048756|[bpoc]|["RA"-tx-15-"RA"-noun-0,"RA"-tx-10-"RA"-noun-0]|TX|2971/2;2452/2|
00000000|MMI|7.01|Additional|C1524062|[ftcn]|["Additional"-tx-31-"additional"-adj-0,"Added"-tx-4-"added"-verb-0]|TX|4335/10;741/5|
00000000|MMI|6.98|Full|C0443225|[qlco]|["Full"-tx-33-"Full"-adj-0,"Full"-tx-3-"Full"-adj-0]|TX|4387/4;326/4|
00000000|MMI|6.98|Serious|C0205404|[qlco]|["Serious"-tx-6-"SERIOUS"-adj-0]|TX|[801/7],[870/7]|
00000000|MMI|6.97|HPS4 gene|C1423767|[gngm]|["LE"-tx-15-"LE"-noun-0,"LE"-tx-7-"LE"-noun-0]|TX|3061/2;1666/2|
00000000|MMI|6.97|LE, Rat Strain|C2697858|[mamm]|["LE"-tx-15-"LE"-noun-0,"LE"-tx-7-"LE"-noun-0]|TX|3061/2;1666/2|
00000000|MMI|6.97|Less Than or Equal to|C0439090|[qnco]|["LE"-tx-15-"LE"-noun-0,"LE"-tx-7-"LE"-noun-0]|TX|3061/2;1666/2|
00000000|MMI|6.93|Now (temporal qualifier)|C1948052|[tmco]|["Now"-tx-21-"now"-adv-0,"Now"-tx-20-"now"-adv-0]|TX|3762/3;3623/3|
00000000|MMI|6.90|Numerous|C0439064|[qnco]|["MULTIPLE"-tx-25-"multiple"-adj-0,"MULTIPLE"-tx-7-"multiple"-adj-0]|TX|3991/8;1795/8|
00000000|MMI|6.88|80%|C3842583|[fndg]|["80%"-tx-16-"80"-integer-0,"80%"-tx-7-"80"-integer-0]|TX|3367/2;2060/2|
00000000|MMI|6.77|Heart|C0018787|[bpoc]|["Cardiac"-tx-32-"cardiac"-adj-0]|TX|4371/7|A07.541
00000000|MMI|5.18|1+|C3816745|[fndg]|["1+"-tx-17-"1"-integer-0]|TX|3495/1|
00000000|MMI|5.18|1+ Score|C2827734|[qnco]|["1+"-tx-17-"1"-integer-0]|TX|3495/1|
00000000|MMI|5.18|1+ Score, WHO|C2981698|[clas]|["1+"-tx-17-"1"-integer-0]|TX|3495/1|
00000000|MMI|5.18|3+ Answer to Question|C3838680|[fndg]|["3+"-tx-28-"3"-integer-0]|TX|4214/1|
00000000|MMI|5.18|3+ Score|C2827736|[qnco]|["3+"-tx-28-"3"-integer-0]|TX|4214/1|
00000000|MMI|5.18|3+ Score, WHO|C2981702|[clas]|["3+"-tx-28-"3"-integer-0]|TX|4214/1|
00000000|MMI|5.18|<3 (qualifier value)|C0439086|[qnco]|["<3"-tx-28-"3"-integer-0]|TX|4214/1|
00000000|MMI|5.18|AV Block First Degree by ECG Finding|C3715208|[fndg]|["1st degree AV block"-tx-15-"1st degree AV block"-noun-0]|TX|3142/19|
00000000|MMI|5.18|ActInformationPrivacyReason <operations>|C3244305|[ftcn]|["operations"-tx-7-"OPERATIONS"-noun-0]|TX|1842/10|
00000000|MMI|5.18|Affecting|C0392760|[ftcn]|["Affecting"-tx-7-"affecting"-verb-0]|TX|1495/9|
00000000|MMI|5.18|Allergic disposition|C3539909|[dsyn]|["Allergy"-tx-7-"ALLERGY"-noun-0]|TX|1287/7|
00000000|MMI|5.18|Allergy - Physicians|C1554743|[prog]|["Allergy"-tx-7-"ALLERGY"-noun-0]|TX|1287/7|
00000000|MMI|5.18|Appearance|C0700364|[qlco]|["APPEAR"-tx-24-"appears"-verb-0]|TX|3876/7|
00000000|MMI|5.18|Arylsulfatase A, human|C3853627|[aapp,enzy]|["ASA"-tx-15-"asa"-noun-0]|TX|2818/3|
00000000|MMI|5.18|Atrial Fibrillation Adverse Event|C1963067|[fndg]|["Atrial fibrillation"-tx-7-"atrial fibrillation"-noun-0]|TX|1742/19|
00000000|MMI|5.18|Changed status|C0443172|[qnco]|["changes"-tx-15-"changes"-verb-0]|TX|3186/7|
00000000|MMI|5.18|Changing|C0392747|[ftcn]|["changes"-tx-15-"changes"-verb-0]|TX|3186/7|
00000000|MMI|5.18|Complication|C0009566|[patf]|["Complications"-tx-7-"Complications"-noun-0]|TX|1479/13|
00000000|MMI|5.18|Continuous|C0549178|[idcn]|["Continued"-tx-11-"continued"-verb-0]|TX|2486/9|
00000000|MMI|5.18|Cow's milk|C0349374|[food]|["Milk"-tx-4-"milk"-noun-0]|TX|606/4|
00000000|MMI|5.18|Delta (difference)|C1705241|[qnco]|["Change"-tx-15-"changes"-verb-0]|TX|3186/7|
00000000|MMI|5.18|Discharge date|C2361123|[tmco]|["Discharge date"-tx-1-"Discharge Date"-noun-0]|TX|0/14|
00000000|MMI|5.18|Discharge date:Time Stamp -- Date and Time:Point in time:^Patient:Quantitative|C2361122|[clna]|["Discharge date"-tx-1-"Discharge Date"-noun-0]|TX|0/14|
00000000|MMI|5.18|Dry|C0205222|[qlco]|["Dry"-tx-35-"dry"-verb-0]|TX|4594/3|
00000000|MMI|5.18|Dryness (characteristic)|C1512080|[qlco]|["Dry"-tx-35-"dry"-verb-0]|TX|4594/3|
00000000|MMI|5.18|First degree atrioventricular block|C0085614|[dsyn]|["1st degree av block"-tx-15-"1st degree AV block"-noun-0]|TX|3142/19|
00000000|MMI|5.18|GRAPEFRUIT EXTRACT|C0440280|[orch,phsu]|["GRAPEFRUIT"-tx-6-"grapefruit"-noun-0]|TX|1035/10|
00000000|MMI|5.18|Grapefruit (food)|C0995150|[food]|["GRAPEFRUIT"-tx-6-"grapefruit"-noun-0]|TX|1035/10|
00000000|MMI|5.18|Grapefruit Flavor|C1365950|[food]|["GRAPEFRUIT"-tx-6-"grapefruit"-noun-0]|TX|1035/10|
00000000|MMI|5.18|HL7PublishingSubSection <operations>|C3244306|[inpr]|["operations"-tx-7-"OPERATIONS"-noun-0]|TX|1842/10|
00000000|MMI|5.18|Hypertension Adverse Event|C1963138|[fndg]|["Hypertension"-tx-7-"hypertension"-noun-0]|TX|1548/12|
00000000|MMI|5.18|Interventional procedure|C0184661|[topp]|["PROCEDURES"-tx-7-"PROCEDURES"-noun-0]|TX|1857/10|
00000000|MMI|5.18|Involvement with|C1314939|[ftcn]|["Affecting"-tx-7-"affecting"-verb-0]|TX|1495/9|
00000000|MMI|5.18|Laboratory test finding|C0587081|[fndg]|["Labs"-tx-15-"LABS"-noun-0]|TX|3074/4|
00000000|MMI|5.18|Late|C0205087|[tmco]|["Later"-tx-9-"Later"-adv-0]|TX|2338/5|
00000000|MMI|5.18|Malignant Neoplasms|C0006826|[neop]|["MALIGNANCY"-tx-25-"malignancy"-noun-0]|TX|4047/10|
00000000|MMI|5.18|Master of Public Health|C1513008|[inpr]|["M.P.H."-tx-2-"M.P.H"-noun-0]|TX|306/5|
00000000|MMI|5.18|Milk - dietary|C2825079|[food]|["MILK"-tx-4-"milk"-noun-0]|TX|606/4|
00000000|MMI|5.18|Milk Specimen|C0444318|[sbst]|["Milk"-tx-4-"milk"-noun-0]|TX|606/4|
00000000|MMI|5.18|NDUFB3 gene|C1417635|[gngm]|["B12"-tx-15-"b12"-noun-0]|TX|2847/3|
00000000|MMI|5.18|Night time|C0240526|[tmco]|["Night"-tx-9-"night"-noun-0]|TX|2349/5|
00000000|MMI|5.18|On admission|C0457453|[tmco]|["On admission"-tx-29-"on admission"-adj-0]|TX|4244/12|
00000000|MMI|5.18|Primary malignant neoplasm|C1306459|[neop]|["Malignancy"-tx-25-"malignancy"-noun-0]|TX|4047/10|
00000000|MMI|5.18|Procedure (set of actions)|C2700391|[acty]|["Procedures"-tx-7-"PROCEDURES"-noun-0]|TX|1857/10|
00000000|MMI|5.18|Recommendation|C0034866|[idcn]|["recommends"-tx-27-"recommends"-verb-0]|TX|4163/10|
00000000|MMI|5.18|Recurrent Malignant Neoplasm|C1458156|[neop]|["recurrence"-tx-18-"recurrence"-noun-1]|TX|3543/10|
00000000|MMI|5.18|Response to antigens|C1314973|[phsf]|["ALLERGY"-tx-7-"ALLERGY"-noun-0]|TX|1287/7|
00000000|MMI|5.18|Retained|C0333118|[ftcn]|["Keep"-tx-35-"keep"-verb-0]|TX|4571/4|
00000000|MMI|5.18|Return to (contextual qualifier) (qualifier value)|C0332156|[qlco]|["Return"-tx-7-"RETURN"-verb-0]|TX|1133/6|
00000000|MMI|5.18|See|C1947903|[acty]|["See"-tx-21-"sees"-verb-0]|TX|3776/4|
00000000|MMI|5.18|Send (transmission)|C1519246|[ftcn]|["Sent"-tx-8-"sent"-verb-0]|TX|2327/4|
00000000|MMI|5.18|Superficial thrombophlebitis|C1510431|[dsyn]|["SUPERFICIAL THROMBOPHLEBITIS"-tx-7-"superficial thrombophlebitis"-noun-0]|TX|1619/28|
00000000|MMI|5.18|Supraventricular Tachycardia Adverse Event|C1963244|[patf]|["Supraventricular tachycardia"-tx-7-"supraventricular tachycardia"-noun-0]|TX|1569/28|
00000000|MMI|5.18|TNFAIP1 gene|C1420797|[gngm]|["B12"-tx-15-"b12"-noun-0]|TX|2847/3|
00000000|MMI|5.18|TNFAIP1 wt Allele|C3538796|[gngm]|["B12"-tx-15-"b12"-noun-0]|TX|2847/3|
00000000|MMI|5.18|treatments and procedures|C0237403|[topp]|["treatments procedures"-tx-7-"TREATMENTS/PROCEDURES"-noun-0]|TX|1880/21|
00000000|MMI|4.12|Allopurinol allergy|C0571136|[dsyn]|["Allopurinol allergy"-tx-15-"allopurinol Allergies"-noun-0]|TX|2882/21|
00000000|MMI|4.12|wake ups|C1170730|[orch,phsu]|["wake up"-tx-9-"woke up"-verb-0]|TX|2359/7|
00000000|MMI|3.98|Communication Contact|C1705415|[idcn]|["Contact"-tx-21-"contacted"-verb-0]|TX|3671/9|
00000000|MMI|3.98|Contact with|C0332158|[ftcn]|["contact"-tx-21-"contacted"-verb-0]|TX|3671/9|
00000000|MMI|3.98|Personal Contact|C3812666|[acty]|["Contact"-tx-21-"contacted"-verb-0]|TX|3671/9|
00000000|MMI|3.98|contact person|C0337611|[popg]|["Contact"-tx-21-"contacted"-verb-0]|TX|3671/9|
00000000|MMI|3.78|TDGF1P3 gene|C3469968|[gngm]|["CR-3"-tx-15-"CR 3"-noun-0]|TX|3117/2,3122/1|
00000000|MMI|3.76|Recurrent cellulitis|C0742020|[dsyn]|["Cellulitis, recurrent"-tx-7-"recurrent cellulitis"-noun-0]|TX|1650/9,1669/10|
00000000|MMI|3.75|5-6|C3843715|[fndg]|["5-6"-tx-1-"5/6"-fraction-0]|TX|16/3|
00000000|MMI|3.75|6/5|C0442749|[fndg]|["5 6"-tx-1-"5/6"-fraction-0]|TX|16/3|
00000000|MMI|3.75|Medication.discharge|C0806915|[fndg]|["Discharge medications"-tx-3-"DISCHARGE MEDICATIONS"-noun-0]|TX|364/21|
00000000|MMI|3.70|Principal Diagnosis:-:Point in time:^Patient:-|C2598194|[clna]|["Principal Diagnosis"-tx-7-"PRINCIPAL DIAGNOSIS"-noun-0]|TX|1348/9,1368/9|
00000000|MMI|3.70|Principal diagnosis|C0332137|[qlco]|["Principal Diagnosis"-tx-7-"PRINCIPAL DIAGNOSIS"-noun-0]|TX|1348/9,1368/9|
00000000|MMI|3.68|Additional comments|C1830770|[fndg]|["Additional comments"-tx-33-"ADDITIONAL COMMENTS"-noun-0]|TX|4397/19|
00000000|MMI|3.68|Admission activity|C0809949|[hlca]|["Admission"-tx-7-"Admission"-noun-0]|TX|1415/9|
00000000|MMI|3.68|Axis|C1522496|[spco]|["Axis"-tx-15-"axis"-noun-0]|TX|3167/4|
00000000|MMI|3.68|CDISC Events Class|C3541888|[clas]|["EVENTS"-tx-15-"events"-noun-0]|TX|3277/6|
00000000|MMI|3.68|Character String Data Type|C3272372|[inpr]|["ST"-tx-15-"ST"-noun-0]|TX|3183/2|
00000000|MMI|3.68|Clinic|C0442592|[hcro,mnob]|["Clinic"-tx-7-"clinic"-noun-0]|TX|1268/6|
00000000|MMI|3.68|Event|C0441471|[evnt]|["Events"-tx-15-"events"-noun-0]|TX|3277/6|
00000000|MMI|3.68|Genus Axis|C0999597|[mamm]|["Axis"-tx-15-"axis"-noun-0]|TX|3167/4|
00000000|MMI|3.68|Nasal Spray|C0461725|[bodm]|["Nasal Spray"-tx-35-"nasal spray"-noun-0]|TX|4543/11|
00000000|MMI|3.68|Primed lymphocyte test|C0201617|[lbpr]|["PLT"-tx-15-"plt"-noun-0]|TX|3099/3|
00000000|MMI|3.68|Status|C0449438|[qlco]|["Status"-tx-3-"STATUS"-noun-0]|TX|318/6|
00000000|MMI|3.68|discharge diagnosis|C1555319|[fndg]|["Discharge diagnosis"-tx-7-"DISCHARGE DIAGNOSIS"-noun-0]|TX|1358/19|
00000000|MMI|3.64|Entered|C1521975|[qlco]|["Entered"-tx-38-"ENTERED"-verb-0]|TX|4748/7|
00000000|MMI|3.64|Hold (action)|C1948035|[acty]|["Hold"-tx-20-"hold"-verb-0]|TX|3598/4|
00000000|MMI|3.64|Hold - dosing instruction fragment|C1553387|[idcn]|["Hold"-tx-20-"hold"-verb-0]|TX|3598/4|
00000000|MMI|3.64|MICROCEPHALY, EPILEPSY, AND DIABETES SYNDROME|C3280240|[dsyn]|["MEDS"-tx-15-"Meds"-noun-0]|TX|2792/4|
00000000|MMI|3.64|hold - Data Operation|C3853841|[ftcn]|["hold"-tx-20-"hold"-verb-0]|TX|3598/4|
00000000|MMI|3.63|C-Circle|C3538933|[celc]|["CC"-tx-7-"CC"-noun-0]|TX|2041/2|
00000000|MMI|3.63|Disposition|C0743223|[idcn]|["Disposition"-tx-3-"DISPOSITION"-noun-0]|TX|336/11|
00000000|MMI|3.63|Disposition Domain|C1705555|[inpr]|["Disposition"-tx-3-"DISPOSITION"-noun-0]|TX|336/11|
00000000|MMI|3.63|Sodium Cation|C0597484|[elii]|["Sodium+"-tx-7-"Sodium"-noun-0]|TX|1126/6|
00000000|MMI|3.63|Sodium Drug Class|C3714642|[phsu]|["SODIUM"-tx-7-"Sodium"-noun-0]|TX|1126/6|
00000000|MMI|3.63|Sodium supplements|C3541959|[phsu]|["Sodium"-tx-7-"Sodium"-noun-0]|TX|1126/6|
00000000|MMI|3.62|Episode of|C0332189|[tmco]|["Episode of"-tx-7-"episodes of"-noun-0]|TX|1804/11|
00000000|MMI|3.61|4+ Answer to question|C3838679|[fndg]|["4+"-tx-40-"4"-fraction-0]|TX|4797/1|
00000000|MMI|3.61|Cardiac - anatomy qualifier|C1522601|[spco]|["Cardiac"-tx-32-"cardiac"-adj-0]|TX|4371/7|
00000000|MMI|3.61|Maxillary right third molar mesial prosthesis|C1552211|[medd]|["1pm"-tx-7-"1pm"-noun-0]|TX|1248/3|
00000000|MMI|3.61|IFI6 gene|C1825561|[gngm]|["6-16"-tx-1-"6/16"-fraction-0]|TX|152/4|
00000000|MMI|3.60|Edema:Finding:Point in time:^Patient:Ordinal|C1717255|[clna]|["Edema"-tx-15-"edema"-noun-0]|TX|3064/5|
00000000|MMI|3.60|Percent in White Blood Count Differential|C1882326|[qnco]|["% WBC"-tx-15-"wbc"-noun-0]|TX|3089/3|
00000000|MMI|3.60|2/5|C0450346|[qnco]|["2 5"-tx-12-"2 5"-fraction-0]|TX|2568/1,2575/1|
00000000|MMI|3.59|ActInformationPrivacyReason <service>|C3245478|[idcn]|["service"-tx-1-"Service"-noun-0]|TX|117/7|
00000000|MMI|3.59|Services|C0557854|[ocac]|["Service"-tx-1-"Service"-noun-0]|TX|117/7|
00000000|MMI|3.59|Software Service|C2825316|[mnob]|["Service"-tx-1-"Service"-noun-0]|TX|117/7|
00000000|MMI|3.59|Base|C0178499|[chvf]|["bases"-tx-15-"bases"-noun-0]|TX|3034/5|
00000000|MMI|3.59|Basilar Rales|C0240859|[fndg]|["Crackles"-tx-15-"crackles"-verb-1]|TX|3022/8|
00000000|MMI|3.59|End|C0444930|[spco]|["End"-tx-40-"END"-noun-0]|TX|4823/3|
00000000|MMI|3.59|Entire nose|C1278896|[bpoc]|["Nose"-tx-35-"nose"-noun-0]|TX|4576/4|
00000000|MMI|3.59|Indication of (contextual qualifier)|C0392360|[idcn]|["Reason"-tx-6-"Reason"-noun-0]|TX|927/6|
00000000|MMI|3.59|Responsible to|C1273518|[fndg]|["Responsible"-tx-7-"Responsible"-adj-0]|TX|1379/11|
00000000|MMI|3.59|Unit dose - Base|C1626935|[qnco]|["Bases"-tx-15-"bases"-noun-0]|TX|3034/5|
00000000|MMI|3.59|seen|C0205397|[qlco]|["Seen"-tx-8-"seen"-verb-0]|TX|2220/4|
00000000|MMI|3.57|Empty (qualifier)|C1880497|[qlco]|["Empty"-tx-3-"empty"-adj-0]|TX|521/5|
00000000|MMI|3.57|Entire stomach|C1278920|[bpoc]|["Stomach"-tx-3-"stomach"-noun-0]|TX|527/7|
00000000|MMI|3.57|Gastric Tissue|C1517454|[tisu]|["STOMACH"-tx-3-"stomach"-noun-0]|TX|527/7|
00000000|MMI|3.57|Stomach structure|C3714551|[bpoc]|["Stomach"-tx-3-"stomach"-noun-0]|TX|527/7|
00000000|MMI|3.57|risk factors - observation list|C1553898|[inpr]|["risk factors"-tx-25-"risk factors"-noun-0]|TX|4000/12|
00000000|MMI|3.56|30%|C3842588|[fndg]|["30%"-tx-4-"30"-fraction-0]|TX|752/2|
00000000|MMI|3.56|Back structure, excluding neck|C1995000|[blor]|["Back, NOS"-tx-24-"back"-adj-0]|TX|3916/4|
00000000|MMI|3.56|Back structure, including back of neck|C0460009|[blor]|["Back"-tx-24-"back"-adj-0]|TX|3916/4|
00000000|MMI|3.56|Dorsal|C0205095|[spco]|["BACK"-tx-24-"back"-adj-0]|TX|3916/4|
00000000|MMI|3.56|Evidence|C3887511|[idcn]|["Evidence"-tx-29-"evidence"-noun-0]|TX|4272/8|
00000000|MMI|3.56|Regimen - CHV concept|C2945654|[inpr]|["regimen"-tx-15-"regimen"-noun-0]|TX|3342/7|
00000000|MMI|3.56|allowing|C0683607|[socb]|["allow"-tx-20-"allow"-verb-0]|TX|3631/5|
00000000|MMI|3.55|Conditional|C1701901|[qlco]|["Contingent"-tx-1-"CONTINGENT"-noun-0]|TX|172/10|
00000000|MMI|3.55|Used by|C1273517|[fndg]|["used"-tx-1-"USED"-verb-0]|TX|227/4|
00000000|MMI|3.53|Discontinued|C1444662|[fndg]|["D/C"-tx-1-"D/C"-noun-0]|TX|214/3|
00000000|MMI|3.53|Doctor of Chiropractic|C1512015|[inpr]|["D.C."-tx-1-"D/C"-noun-0]|TX|214/3|
00000000|MMI|3.50|Antacid Effects|C1383090|[phsf]|["Antacid"-tx-4-"antacid"-noun-0]|TX|615/7|
00000000|MMI|3.50|Causing|C0678227|[ftcn]|["Causing"-tx-7-"Causing"-adj-0]|TX|1407/7|
00000000|MMI|3.50|Christian|C0344346|[popg]|["Christian"-tx-1-"CHRISTIAN"-noun-0]|TX|281/9|
00000000|MMI|3.50|Diagnosis Type - Final|C1546485|[idcn]|["Final"-tx-1-"FINAL"-adj-0]|TX|32/5|
00000000|MMI|3.50|End-stage|C0205088|[qlco]|["Final"-tx-1-"FINAL"-adj-0]|TX|32/5|
00000000|MMI|3.50|Final|C3853528|[tmco]|["Final"-tx-1-"FINAL"-adj-0]|TX|32/5|
00000000|MMI|3.50|NADPH:sulfur oxidoreductase activity|C2700623|[moft]|["NSR"-tx-15-"NSR"-noun-0]|TX|3132/3|
00000000|MMI|3.50|Neutral Sidebent Rotated|C1704493|[patf]|["NSR"-tx-15-"NSR"-noun-0]|TX|3132/3|
00000000|MMI|3.50|Per Nanoliter|C3892223|[qnco]|["/nL"-tx-15-"nl"-noun-0]|TX|3164/2|
00000000|MMI|3.50|Stop brand of fluoride|C0723457|[inch,phsu]|["stopping"-tx-27-"stopping"-adj-0]|TX|4174/8|
00000000|MMI|3.50|Yes (indicator)|C1705108|[cnce]|["YES"-tx-1-"YES"-noun-0]|TX|252/3|
00000000|MMI|3.50|Yes - Yes/no indicator|C1549445|[idcn]|["Yes"-tx-1-"YES"-noun-0]|TX|252/3|
00000000|MMI|3.50|acute|C0205178|[tmco]|["ACUTE"-tx-15-"acute"-adj-0]|TX|3177/5|
00000000|MMI|3.50|dictated - DocumentCompletion|C1609990|[idcn]|["Dictated"-tx-38-"dictated"-adj-0]|TX|4731/8|
00000000|MMI|3.50|dictated - ParticipationMode|C1548384|[ftcn]|["dictated"-tx-38-"dictated"-adj-0]|TX|4731/8|
00000000|MMI|3.50|nanolitre|C0560008|[qnco]|["nL"-tx-15-"nl"-noun-0]|TX|3164/2|
00000000|MMI|3.49|Not Applicable|C1272460|[qlco]|["NOT APPLICABLE"-tx-7-"Not Applicable"-adj-0]|TX|1149/14|
00000000|MMI|3.49|Package Type Not Applicable|C4049872|[ftcn]|["Not Applicable"-tx-7-"Not Applicable"-adj-0]|TX|1149/14|
00000000|MMI|3.49|ferrous sulfate 325 MG|C1125139|[clnd]|["ferrous sulfate 325 MG"-tx-4-"FERROUS SULFATE 325 MG"-noun-0]|TX|536/22|
00000000|MMI|3.48|Superficial femoral vein structure|C1301369|[bpoc]|["Superficial Femoral vein"-tx-24-"superficial femoral vein"-noun-0]|TX|3953/24|
00000000|MMI|3.48|Rehabilitation - specialty|C1306847|[bmod]|["Rehabilitation"-tx-3-"Rehabilitation"-noun-0]|TX|349/14|
00000000|MMI|3.48|gram|C0439208|[qnco]|["GRAM"-tx-7-"gram"-noun-0]|TX|1121/4|
00000000|MMI|3.47|1/5|C0450316|[qnco]|["1/5"-tx-4-"1 5"-integer-0]|TX|645/1,674/1|
00000000|MMI|3.47|Liter per Hour|C2346686|[qnco]|["h l"-tx-24-"h L"-noun-0]|TX|3947/1,3951/1|
00000000|MMI|3.47|10%|C3842590|[fndg]|["10%"-tx-7-"10"-fraction-0]|TX|1245/2|
00000000|MMI|3.47|Before|C0332152|[tmco]|["Prior"-tx-25-"prior"-adj-0]|TX|4062/5|
00000000|MMI|3.47|Primary|C0205225|[qlco]|["Principal"-tx-7-"PRINCIPAL"-adj-0]|TX|1348/9|
00000000|MMI|3.47|Prior Medication Usage|C2826257|[evnt]|["PRIOR"-tx-25-"prior"-adj-0]|TX|4062/5|
00000000|MMI|3.47|Teaching principal|C0401925|[prog]|["Principal"-tx-7-"PRINCIPAL"-adj-0]|TX|1348/9|
00000000|MMI|3.47|Usage|C0457083|[ftcn]|["Use"-tx-35-"use"-noun-0]|TX|4533/3|
00000000|MMI|3.47|Use - dosing instruction imperative|C1947944|[inpr]|["Use"-tx-35-"use"-noun-0]|TX|4533/3|
00000000|MMI|3.46|ABD tumor staging notation|C0449202|[inpr]|["ABD"-tx-15-"abd"-adj-0]|TX|3042/3|
00000000|MMI|3.46|Absence of Biallelic TCRgamma Deletion|C3811055|[comd]|["ABD"-tx-15-"abd"-adj-1]|TX|3042/3|
00000000|MMI|3.46|Benign|C0205183|[qlco]|["BENIGN"-tx-15-"benign"-adj-0]|TX|3046/6|
00000000|MMI|3.46|Minimum|C1524031|[qlco]|["Trace"-tx-15-"trace"-noun-0]|TX|3055/5|
00000000|MMI|3.46|Sequence Chromatogram|C1883002|[ftcn]|["Trace"-tx-15-"trace"-noun-0]|TX|3055/5|
00000000|MMI|3.46|trace amount|C0442822|[qnco]|["Trace"-tx-15-"trace"-noun-0]|TX|3055/5|
00000000|MMI|3.45|Cholesterol measurement test|C0201950|[lbpr]|["CHOL"-tx-7-"chol"-noun-0]|TX|1095/4|
00000000|MMI|3.45|House (environment)|C2003847|[mnob]|["House"-tx-7-"House"-noun-0]|TX|1083/5|
00000000|MMI|3.45|SAT1 protein, human|C2744672|[aapp,enzy]|["SAT"-tx-7-"sat"-noun-0]|TX|1104/3|
00000000|MMI|3.45|SAT1 wt Allele|C1705827|[gngm]|["SAT"-tx-7-"sat"-noun-0]|TX|1104/3|
00000000|MMI|3.45|Bedtime (qualifier value)|C0521112|[tmco]|["Bedtime"-tx-6-"BEDTIME"-noun-0]|TX|987/7|
00000000|MMI|3.45|Document completion status - Documented|C1609436|[inpr]|["Documented"-tx-24-"documented"-adj-0]|TX|3936/10|
00000000|MMI|3.45|Documented|C1301725|[hlca]|["Documented"-tx-24-"documented"-adj-0]|TX|3936/10|
00000000|MMI|3.45|PSMD4 wt Allele|C4049859|[gngm]|["AF"-tx-15-"AF"-noun-0]|TX|2951/2|
00000000|MMI|3.45|Respiratory Domain|C2986904|[idcn]|["RE"-tx-1-"Re"-noun-0]|TX|109/2|
00000000|MMI|3.45|Retinol equivalents|C0556581|[qnco]|["{RE}"-tx-1-"Re"-noun-0]|TX|109/2|
00000000|MMI|3.45|Room of building - Study|C0557651|[mnob]|["Study"-tx-7-"Study"-noun-0]|TX|1397/5|
00000000|MMI|3.45|Study|C2603343|[resa]|["Study"-tx-7-"Study"-noun-0]|TX|1397/5|
00000000|MMI|3.45|Three times daily|C0556984|[tmco]|["TID"-tx-4-"TID"-noun-0]|TX|562/3|
00000000|MMI|3.45|three times a day at institution-specified times|C1610169|[tmco]|["TID"-tx-4-"TID"-noun-0]|TX|562/3|
00000000|MMI|3.45|/40|C0439509|[tmco]|["/40"-tx-3-"40"-integer-0]|TX|408/2|
00000000|MMI|3.45|40%|C3842587|[qnco]|["40%"-tx-3-"40"-integer-0]|TX|408/2|
00000000|MMI|3.45|Alert|C3665546|[ftcn]|["Alert"-tx-4-"Alert"-adj-0]|TX|714/5|
00000000|MMI|3.45|Alert:Type:Point in time:^Patient:Nominal|C3669039|[clna]|["Alert"-tx-4-"Alert"-adj-0]|TX|714/5|
00000000|MMI|3.45|Consciousness clear|C0239110|[fndg]|["ALERT"-tx-4-"Alert"-adj-0]|TX|714/5|
00000000|MMI|3.43|Appropriate|C1548787|[qlco]|["Appropriate"-tx-15-"appropriate"-adj-0]|TX|3314/11|
00000000|MMI|3.43|Distal|C0205108|[spco]|["far"-tx-24-"far"-adj-0]|TX|3912/3|
00000000|MMI|3.43|Further|C1517331|[spco]|["Further"-tx-29-"further"-adj-0]|TX|4264/7|
00000000|MMI|3.43|Hospital course|C0489547|[fndg]|["Hospital course"-tx-7-"HOSPITAL COURSE"-noun-0]|TX|1976/15|
00000000|MMI|3.43|Hospital course:Finding:Point in time:^Patient:Narrative|C0488549|[clna]|["Hospital course"-tx-7-"HOSPITAL COURSE"-noun-0]|TX|1976/15|
00000000|MMI|3.43|Evaluation procedure|C1261322|[hlca]|["Evaluation"-tx-1-"evaluation"-noun-0]|TX|198/10|
00000000|MMI|3.42|About The Same|C2346711|[qlco]|["Unchanged"-tx-15-"unchanged"-adj-0]|TX|3211/9|
00000000|MMI|3.42|Administration procedure|C1533734|[topp]|["Treatment"-tx-7-"Treatment"-noun-0]|TX|1505/9|
00000000|MMI|3.42|Biomaterial Treatment|C1705169|[cnce]|["Treatment"-tx-7-"Treatment"-noun-0]|TX|1505/9|
00000000|MMI|3.42|CR1 gene|C1413694|[gngm]|["CR1"-tx-15-"cr1"-noun-0]|TX|3233/3|
00000000|MMI|3.42|Motor vehicle accident|C2939181|[phpr]|["MVA"-tx-7-"MVA"-noun-0]|TX|1524/3|
00000000|MMI|3.42|No status change|C0442739|[fndg]|["Unchanged"-tx-15-"unchanged"-adj-1]|TX|3211/9|
00000000|MMI|3.42|Therapeutic procedure|C0087111|[topp]|["Treatment"-tx-7-"Treatment"-noun-0]|TX|1505/9|E02
00000000|MMI|3.42|Treating|C1522326|[ftcn]|["Treatment"-tx-7-"Treatment"-noun-0]|TX|1505/9|
